Brighton Jones’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,427
Closed -$108K – 1487
2026
Q2
$108K Buy
+11,427
New +$102K ﹤0.01% 1306
2022
Q1
– Sell
-1,496
Closed -$214K – 537
2021
Q4
$214K Buy
+1,496
New +$257K 0.01% 480

Other funds holding NVAX

Brighton Jones's NVAX Position: Q3 2026 in Review

Brighton Jones sold out of Novavax (NVAX) in Q3 2026, closing a stake of 11,427 shares — an estimated $108K sold.

Brighton Jones first reported a position in NVAX in Q4 2021 and held it in 2 quarters. The position peaked at $214K in Q4 2021. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Brighton Jones reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 11,427 Novavax shares in Q3 2026, an estimated $108K.
  • Brighton Jones first reported a position in Novavax in Q4 2021 and held it in 2 quarters.
  • Brighton Jones's Novavax position peaked at $214K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.